- Gene-Sequencing Company Illumina to Sell Cancer Test DeveloperThe New York Times
- Court Sides With FTC Finding Illumina-Grail Deal AnticompetitiveThe Wall Street Journal
- Illumina to divest cancer test maker Grail after antitrust battlesReuters
- Illumina Plans to Sell Grail After US Antitrust Appeal RulingBloomberg
- Grail spinoff by Illumina should end disastrous merger attempt – STATSTAT